{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:40:43Z","timestamp":1780386043794,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.rvsc.2024.105221","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T08:10:58Z","timestamp":1710144658000},"page":"105221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A randomized double-blind clinical trial: Comparison of oclacitinib with a traditional Chinese herbal medicine product (Dihuang Guiqin capsule) in the treatment of canine atopic dermatitis"],"prefix":"10.1016","volume":"171","author":[{"given":"Jun-Jie","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2024.105221_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/9781119278368.ch2.1","article-title":"A review of the roles of keratinocyte-derived cytokines and chemokines in the pathogenesis of atopic dermatitis in humans and dogs","volume":"28","author":"Asahina","year":"2017","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12917-016-0714-8","article-title":"Medicinal plants\u2013prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review","volume":"12","author":"Ayrle","year":"2016","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.rvsc.2024.105221_bb0015","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J. Clin. Cell Immunol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/vetsci9040149","article-title":"Clinical guidelines for the use of antipruritic drugs in the control of the most frequent pruritic skin diseases in dogs","volume":"9","author":"Bruet","year":"2022","journal-title":"Vet. Sci."},{"key":"10.1016\/j.rvsc.2024.105221_bb0025","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.lfs.2003.09.047","article-title":"Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer","volume":"74","author":"Cai","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.rvsc.2024.105221_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.927304","article-title":"Efficacy and safety of Chinese herbal medicine for atopic dermatitis: evidence from eight high-quality randomized placebo-controlled trials","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.rvsc.2024.105221_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12762","article-title":"Alterations in circulating concentrations of IL-17, IL-31 and total IgE in dogs with atopic dermatitis","volume":"30","author":"Chaudhary","year":"2019","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.intimp.2007.10.006","article-title":"Macrophage immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis Fish","volume":"8","author":"Cheng","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-3164.2009.00758.x","article-title":"A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis","volume":"21","author":"Favrot","year":"2010","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2016.11.020","article-title":"Demonstration of rebound phenomenon following abrupt withdrawal of the JAK1 inhibitor oclacitinib","volume":"794","author":"Fukuyama","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.rvsc.2024.105221_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13601-018-0228-5","article-title":"Atopic dermatitis in cats and dogs: a difficult disease for animals and owners","volume":"8","author":"Gedon","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.rvsc.2024.105221_bb0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-3164.2012.01098.x","article-title":"Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis","volume":"24","author":"Gonzales","year":"2013","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jvp.12101","article-title":"Oclacitinib (APOQUEL(\u00ae)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy","volume":"37","author":"Gonzales","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2024.105221_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12917-015-0515-5","article-title":"Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification","volume":"11","author":"Hensel","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.rvsc.2024.105221_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11655-016-2535-9","article-title":"Chinese medicines reported to have effects on contact dermatitis in the last 20 years","volume":"24","author":"Jung","year":"2018","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.rvsc.2024.105221_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jep.2012.04.053","article-title":"Effect of Sophora flavescens Aiton extract on degranulation of mast cells and contact dermatitis induced by dinitrofluorobenzene in mice","volume":"142","author":"Kim","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/ani13081299","article-title":"Role of prednisolone in platelet activation by inhibiting TxA generation through the regulation of cPLA phosphorylation","volume":"13","author":"Kim","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.rvsc.2024.105221_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jdv.13794","article-title":"Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody","volume":"31","author":"Lewis","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-3164.2010.00899.x","article-title":"Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners","volume":"21","author":"Linek","year":"2010","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/vde.12186","article-title":"A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs","volume":"26","author":"Little","year":"2015","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/vde.12965","article-title":"Advances in our understanding of canine atopic dermatitis","volume":"32","author":"Marsella","year":"2021","journal-title":"Vet. Dermatol."},{"issue":"4","key":"10.1016\/j.rvsc.2024.105221_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-3164.2002.00299.x","article-title":"Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study[J]","volume":"13","author":"Marsella","year":"2002","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0125","first-page":"984","article-title":"Chinese medicinal herbs as source of antioxidant compounds\u2013where tradition meets the future","volume":"20","author":"Matkowski","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.rvsc.2024.105221_bb0130","first-page":"375","article-title":"Treatment of organic livestock with medicinal plants: a systematic review of European ethnoveterinary research","volume":"21","author":"Mayer","year":"2014","journal-title":"Forsch. Komplementmed."},{"key":"10.1016\/j.rvsc.2024.105221_bb0135","first-page":"1189","article-title":"Research progress on canine pruritus skin disease (in Chinese)","volume":"03","author":"Ming","year":"2022","journal-title":"China Anim. Husb. Vet. Med."},{"key":"10.1016\/j.rvsc.2024.105221_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.0959-4493.2001.00267.x","article-title":"A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis","volume":"12","author":"Nagle","year":"2001","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/vde.13193","article-title":"A randomized, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis","volume":"34","author":"Nishiyama","year":"2023","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3164.2011.00992.x","article-title":"Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis","volume":"23","author":"Nuttall","year":"2012","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2460\/javma.254.11.1291","article-title":"Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs","volume":"254","author":"Nuttall","year":"2019","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.rvsc.2024.105221_bb0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2460\/javma.2002.221.370","article-title":"Randomized controlled trial of the efficacy of cyclosporin in the treatment of atopic dermatitis in dogs","volume":"221","author":"Olivry","year":"2002","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.rvsc.2024.105221_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/vde.12107","article-title":"Validation of the canine atopic dermatitis extent and severity index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs","volume":"25","author":"Olivry","year":"2014","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vde.13134","article-title":"A randomised controlled trial testing the rebound-preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis","volume":"34","author":"Olivry","year":"2023","journal-title":"Vet. Dermatol."},{"issue":"2","key":"10.1016\/j.rvsc.2024.105221_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-3164.2008.00728.x","article-title":"Further validation of a pruritus severity scale for use in dogs","volume":"20","author":"Rybn\u00edcek","year":"2009","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0180","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.rvsc.2024.105221_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-967126","article-title":"In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components","volume":"73","author":"Shin","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.rvsc.2024.105221_bb0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fncel.2019.00422","article-title":"Mast cells and sensory nerves contribute to neurogenic inflammation and pruritus in chronic skin inflammation","volume":"13","author":"Siiskonen","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.rvsc.2024.105221_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-3164.2005.00491.x","article-title":"A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs","volume":"17","author":"Steffan","year":"2006","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/vde.13062","article-title":"Validation of the 0-10 verbal numeric scale for assessment of pruritus severity in dogs","volume":"33","author":"Strzok","year":"2022","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0205","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/aps.2010.42","article-title":"Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice","volume":"31","author":"Trinh","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.rvsc.2024.105221_bb0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2005.05.029","article-title":"Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma","volume":"116","author":"Wen","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0220","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.neuron.2021.07.020","article-title":"Dissecting the precise nature of itch-evoked scratching","volume":"109","author":"Wimalasena","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.rvsc.2024.105221_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/vde.12761","article-title":"Canine pruritus visual analog scale: how does it capture owners\u2019 perception of their pet\u2019s itching level?","volume":"30","author":"Young","year":"2019","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.rvsc.2024.105221_bb0230","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.intimp.2010.06.020","article-title":"Therapeutic effects of baicalein on atopic dermatitis-like skin lesions of NC\/Nga mice induced by dermatophagoides pteronyssinus","volume":"10","author":"Yun","year":"2010","journal-title":"Int. Immunopharmacol."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528824000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528824000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T09:36:26Z","timestamp":1734600986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528824000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":45,"alternative-id":["S0034528824000870"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2024.105221","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized double-blind clinical trial: Comparison of oclacitinib with a traditional Chinese herbal medicine product (Dihuang Guiqin capsule) in the treatment of canine atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2024.105221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105221"}}